Name: SLN Balance Sheet - Silence Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SLN - Silence Therapeutics PLC

USD | NASDAQ | Healthcare

SLN Balance Sheet - Silence Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q4 FY 22	Q4 FY 21
Cash And Short Term Investments
Cash And Equivalents	5.7	11.3	82.0	41.7	64.9	121.3	-	-	-	-	-	-
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	64.4	73.8	20.2	72.4	71.6	26.0	-	-	-	-	-	-
Cash And Short Term Investments	70.1	85.1	102.2	114.2	136.5	147.3	-	-	-	-	-	-
Receivables
Accounts Receivable	0.0	0.0	0.0	0.1	0.0	1.0	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-
Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.0
Common Equity
Common Stock	10.3	10.3	10.3	10.3	10.3	10.3	-	-	-	-	8.2	-
Additional Paid In Capital	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Cash And Short Term Investments
Cash And Equivalents	11.3	121.3	68.8	-	-
Restricted Cash	-	-	-	-	-
Short Term Investments	73.8	26.0	-	-	-
Cash And Short Term Investments	85.1	147.3	68.8	-	-
Receivables
Accounts Receivable	0.0	1.0	0.3	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	-	-	-	-	-
Other Current Assets	11.5	14.7
Non-Current Assets
Property, Plant & Equipment Gross	5.5	6.3	6.4	-	-
Accumulated Depreciation	4.0	4.5	4.5	-	-
Property,Plant & Equipment Net	1.6
Current Liabilities
Accounts Payable	-	-	-	-	-
Short Term Debt	-	-	-	-	-
Deferred Revenue Current	0.2	0.3
Non-Current Liabilities
Long Term Debt	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.1	0.0	0.1	-	-
Deferred Revenue Non-Current	55.5
Common Equity
Common Stock	10.3	10.3	8.8	8.2	-
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	(562.6)	(474.0)
Supplementary Data
Total Debt	-	-	-	-	-
Net debt	-	-	-	-	-
Working Capital	105.0	170.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)